Dr. Bushra Akhtar has earned her Doctor of Philosophy (Pharmacology) degree from University of Agriculture, Faisalabad, Pakistan. She studied Master of Philosophy (Pharmacology and Toxicology) from University of Veterinary and Animal Sciences, Lahore, Pakistan. She did Pharm-D from Bahauddin Zakariya University, Multan, Pakistan. She is working as lecturer in Department of Pharmacy, University of Agriculture, Faisalabad, Pakistan. She has published 60 peer reviewed articles with impact factor around 160. She has one national patent to her credit. Dr. Bushra Akhtar has produced around 20 postgraduate students as major supervisor. She is the editorial board member of 02 impact factor journals. Dr. Faqir Muhammad has earned his Doctor of Philosophy degree in 2004 from North Carolina State University U.S.A and M.Sc. (Hons.) and DVM degrees from University of Agriculture Faisalabad. Dr. Faqir Muhammad is working as Professor and Chairman, Department of Biosciences,Faculty of Veterinary Sciences, Bahauddin Zakariya University Multan.  He has the experience of working as Research Assistant Professor at Kansas State University, USA for two years. He is a full member of the Society of Toxicology. He has been awarded with Star Award 2005, the millennium life time award 2008, research productivity award 2012. He has contributed a number of book chapters in international books. He has published more than 150 peer reviewed articles with an impact factor of 255 and more than 3500 citations to his credit. Dr. Faqir Muhammad has won various Research Projects from National Funding Agencies worth of more than Rs 14 million.Dr. Ali Sharif is currently serving as an Assistant Professor and Incharge at Department of Pharmacology, Institute of Pharmacy, Lahore College for Women University, Lahore. He received his PhD in Pharmacology and Toxicology in 2016, University of Veterinary and Animal Sciences Lahore. He studied Master of Philosophy (Pharmaceutics) and B-Pharm from Bahauddin Zakariya University, Multan, Pakistan.  He has a teaching experience of more than 13 years. He has produced more than 25 M.Phil. & Ph.D students as major supervisor. He is author of more than 65 research papers and book chapters with a cumulative impact factor of 150. He is the editorial board member of 03 impact factor journals.

• SECTION-I. INTRODUCTION TO NANOMEDICINE.- Chapter-I. Nanomedicine: Present perspectives and future challenges.- Chapter-II. Advantages of Nanomedicine over Conventional Therapeutics.- SECTION-II. NANOMEDICINE IN TREATMENT OF DISEASES.- Chapter-III. Nanomedicines for the treatment of bacterial diseases.- Chapter-IV. Nanomedicine in the treatment of viral diseases.- Chapter-V. Nanomedicines in the treatment of nervous system disorders.- Chapter-VI. Nanomedicines in treatment of cancer.- Chapter-VII. Nanomedicine in the treatment of Metabolic diseases.- Chapter-VIII. Nanomedicines in the Treatment of Fungal Diseases.- Chapter-IX. Nanomedicines in the treatment of skin diseases.- Chapter-X. Nanomedicines in the treatment of gastrointestinal disorders.- Chapter-XI. Nanomedicines in Treatment of Cardiovascular Diseases.- SECTION-III. CURRENT STATUS OF NANOMEDICINE IN CLINICAL APPLICATIONS.- Chapter-XII. Current status of nanomedicines in clinical practice.

Dr. Bushra Akhtar has earned her Doctor of Philosophy (Pharmacology) degree from University of Agriculture, Faisalabad, Pakistan. She studied Master of Philosophy (Pharmacology and Toxicology) from University of Veterinary and Animal Sciences, Lahore, Pakistan. She did Pharm-D from Bahauddin Zakariya University, Multan, Pakistan. She is working as lecturer in Department of Pharmacy, University of Agriculture, Faisalabad, Pakistan. She has published 60 peer reviewed articles with impact factor around 160. She has one national patent to her credit. Dr. Bushra Akhtar has produced around 20 postgraduate students as major supervisor. She is the editorial board member of 02 impact factor journals. Dr. Faqir Muhammad has earned his Doctor of Philosophy degree in 2004 from North Carolina State University U.S.A and M.Sc. (Hons.) and DVM degrees from University of Agriculture Faisalabad. Dr. Faqir Muhammad is working as Professor and Chairman, Department of Biosciences,Faculty of Veterinary Sciences, Bahauddin Zakariya University Multan.  He has the experience of working as Research Assistant Professor at Kansas State University, USA for two years. He is a full member of the Society of Toxicology. He has been awarded with Star Award 2005, the millennium life time award 2008, research productivity award 2012. He has contributed a number of book chapters in international books. He has published more than 150 peer reviewed articles with an impact factor of 255 and more than 3500 citations to his credit. Dr. Faqir Muhammad has won various Research Projects from National Funding Agencies worth of more than Rs 14 million.Dr. Ali Sharif is currently serving as an Assistant Professor and Incharge at Department of Pharmacology, Institute of Pharmacy, Lahore College for Women University, Lahore. He received his PhD in Pharmacology and Toxicology in 2016, University of Veterinary and Animal Sciences Lahore. He studied Master of Philosophy (Pharmaceutics) and B-Pharm from Bahauddin Zakariya University, Multan, Pakistan.  He has a teaching experience of more than 13 years. He has produced more than 25 M.Phil. & Ph.D students as major supervisor. He is author of more than 65 research papers and book chapters with a cumulative impact factor of 150. He is the editorial board member of 03 impact factor journals.

• SECTION-I. INTRODUCTION TO NANOMEDICINE.- Chapter-I. Nanomedicine: Present perspectives and future challenges.- Chapter-II. Advantages of Nanomedicine over Conventional Therapeutics.- SECTION-II. NANOMEDICINE IN TREATMENT OF DISEASES.- Chapter-III. Nanomedicines for the treatment of bacterial diseases.- Chapter-IV. Nanomedicine in the treatment of viral diseases.- Chapter-V. Nanomedicines in the treatment of nervous system disorders.- Chapter-VI. Nanomedicines in treatment of cancer.- Chapter-VII. Nanomedicine in the treatment of Metabolic diseases.- Chapter-VIII. Nanomedicines in the Treatment of Fungal Diseases.- Chapter-IX. Nanomedicines in the treatment of skin diseases.- Chapter-X. Nanomedicines in the treatment of gastrointestinal disorders.- Chapter-XI. Nanomedicines in Treatment of Cardiovascular Diseases.- SECTION-III. CURRENT STATUS OF NANOMEDICINE IN CLINICAL APPLICATIONS.- Chapter-XII. Current status of nanomedicines in clinical practice.

Dr. Bushra Akhtar has earned her Doctor of Philosophy (Pharmacology) degree from University of Agriculture, Faisalabad, Pakistan. She studied Master of Philosophy (Pharmacology and Toxicology) from University of Veterinary and Animal Sciences, Lahore, Pakistan. She did Pharm-D from Bahauddin Zakariya University, Multan, Pakistan. She is working as lecturer in Department of Pharmacy, University of Agriculture, Faisalabad, Pakistan. She has published 60 peer reviewed articles with impact factor around 160. She has one national patent to her credit. Dr. Bushra Akhtar has produced around 20 postgraduate students as major supervisor. She is the editorial board member of 02 impact factor journals. Dr. Faqir Muhammad has earned his Doctor of Philosophy degree in 2004 from North Carolina State University U.S.A and M.Sc. (Hons.) and DVM degrees from University of Agriculture Faisalabad. Dr. Faqir Muhammad is working as Professor and Chairman, Department of Biosciences,Faculty of Veterinary Sciences, Bahauddin Zakariya University Multan.  He has the experience of working as Research Assistant Professor at Kansas State University, USA for two years. He is a full member of the Society of Toxicology. He has been awarded with Star Award 2005, the millennium life time award 2008, research productivity award 2012. He has contributed a number of book chapters in international books. He has published more than 150 peer reviewed articles with an impact factor of 255 and more than 3500 citations to his credit. Dr. Faqir Muhammad has won various Research Projects from National Funding Agencies worth of more than Rs 14 million.Dr. Ali Sharif is currently serving as an Assistant Professor and Incharge at Department of Pharmacology, Institute of Pharmacy, Lahore College for Women University, Lahore. He received his PhD in Pharmacology and Toxicology in 2016, University of Veterinary and Animal Sciences Lahore. He studied Master of Philosophy (Pharmaceutics) and B-Pharm from Bahauddin Zakariya University, Multan, Pakistan.  He has a teaching experience of more than 13 years. He has produced more than 25 M.Phil. & Ph.D students as major supervisor. He is author of more than 65 research papers and book chapters with a cumulative impact factor of 150. He is the editorial board member of 03 impact factor journals.

• SECTION-I. INTRODUCTION TO NANOMEDICINE.- Chapter-I. Nanomedicine: Present perspectives and future challenges.- Chapter-II. Advantages of Nanomedicine over Conventional Therapeutics.- SECTION-II. NANOMEDICINE IN TREATMENT OF DISEASES.- Chapter-III. Nanomedicines for the treatment of bacterial diseases.- Chapter-IV. Nanomedicine in the treatment of viral diseases.- Chapter-V. Nanomedicines in the treatment of nervous system disorders.- Chapter-VI. Nanomedicines in treatment of cancer.- Chapter-VII. Nanomedicine in the treatment of Metabolic diseases.- Chapter-VIII. Nanomedicines in the Treatment of Fungal Diseases.- Chapter-IX. Nanomedicines in the treatment of skin diseases.- Chapter-X. Nanomedicines in the treatment of gastrointestinal disorders.- Chapter-XI. Nanomedicines in Treatment of Cardiovascular Diseases.- SECTION-III. CURRENT STATUS OF NANOMEDICINE IN CLINICAL APPLICATIONS.- Chapter-XII. Current status of nanomedicines in clinical practice.